Literature DB >> 10892777

Breaking the silence: setting realistic priorities for AIDS control in less-developed countries.

M Ainsworth1, W Teokul.   

Abstract

The AIDS pandemic is a human tragedy that is threatening development in the poorest countries. There is no cure or vaccine, but the tools to control the epidemic already exist. Nevertheless, there are few examples of national AIDS control programmes that have had an impact on the epidemic. We (an economist and a planner) attribute this to the reluctance of governments to confront AIDS and a failure to prioritise activities in the face of severe financial and administrative constraints. When implementation capacity is weak, expanding the number of activities may not improve programme effectiveness. Rather, by implementing a smaller, core set of the most cost-effective activities on a national scale, policymakers could have a huge effect on the overall epidemic in a sustained way and provide a foundation for expansion. We propose three core priorities for AIDS control in poor countries for prevention, treatment, and mitigation of the impact.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Developing Countries; Diseases; Government Sponsored Programs; Hiv Infections; Organization And Administration; Program Development; Programs; Recommendations; Viral Diseases

Mesh:

Year:  2000        PMID: 10892777     DOI: 10.1016/S0140-6736(00)02440-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  Back to basics in HIV prevention: focus on exposure.

Authors:  Elizabeth Pisani; Geoff P Garnett; Nicholas C Grassly; Tim Brown; John Stover; Catherine Hankins; Neff Walker; Peter D Ghys
Journal:  BMJ       Date:  2003-06-21

Review 2.  Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups.

Authors:  Onyema Ogbuagu; R Douglas Bruce
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

3.  The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review.

Authors:  Mira Johri; Denis Ako-Arrey
Journal:  Cost Eff Resour Alloc       Date:  2011-02-09

4.  Local Demand for a Global Intervention: Policy Priorities in the Time of AIDS.

Authors:  Kim Yi Dionne
Journal:  World Dev       Date:  2012-12-01

5.  Corruption and oil exploration: expert agreement about the prevention of HIV/AIDS in the Niger Delta of Nigeria.

Authors:  Isidore A Udoh; Ronald M Stammen; Joanne E Mantell
Journal:  Health Educ Res       Date:  2007-09-28

6.  Building adherence-competent communities: factors promoting children's adherence to anti-retroviral HIV/AIDS treatment in rural Zimbabwe.

Authors:  Catherine Campbell; Morten Skovdal; Zivai Mupambireyi; Claudius Madanhire; Constance Nyamukapa; Simon Gregson
Journal:  Health Place       Date:  2011-09-14       Impact factor: 4.078

7.  From population to HIV: the organizational and structural determinants of HIV outcomes in sub-Saharan Africa.

Authors:  Rachel Sullivan Robinson
Journal:  J Int AIDS Soc       Date:  2011-09-27       Impact factor: 5.396

8.  Adherence to HAART: Africans take medicines more faithfully than North Americans.

Authors:  Amir Attaran
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

Review 9.  The distribution of new HIV infections by mode of exposure in Morocco.

Authors:  Ghina R Mumtaz; Silva P Kouyoumjian; Nahla Hilmi; Ahmed Zidouh; Houssine El Rhilani; Kamal Alami; Aziza Bennani; Eleanor Gouws; Peter Denis Ghys; Laith J Abu-Raddad
Journal:  Sex Transm Infect       Date:  2013-02-14       Impact factor: 3.519

10.  Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo.

Authors:  François Boillot; Laetitia Serrano; Jeremie Muwonga; Jean Pierre Kabuayi; Alain Kambale; Fidèle Mutaka; Paula I Fujiwara; Josef Decosas; Martine Peeters; Eric Delaporte
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.